MAIA Biotechnology, Inc.
MAIA· NYSE
Released Aug 11, 2025, before the open
10-Q filed Aug 11, 2025, 42 days after period end · 0001641172-25-022899
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$5.35M | -$8.88M | -$4.52M | -$3.31M |
| EPS Diluted | -$0.18 | -$0.40 | -$0.35 | -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MAIA Biotechnology, Inc. · CIK 1878313 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2025 · filed Aug 11, 2025 · 42 d after period end
2.6% from the close of Aug 8, 2025 to the close of Aug 11, 2025, the first after the release.